• Tue news: Pfizer explores sale of hospital drugs unit. FDA declines full approval of Ocaliva. AZ better than expected Q3 results. Pfizer, Lilly telehealth platforms draw scrutiny. 23andMe cutting lays off 40%. See more on our front page

CBER director Peter Marks says FDA is growing to keep up with cell and gene therapies

cafead

Administrator
Staff member
  • cafead   Mar 01, 2023 at 06:52: PM
via CBER director Peter Marks spelled out FDA’s plans to keep up with the fast-growing cell and gene therapy space on Tuesday, while also advocating for the use of accelerated approvals.

“This area has grown so much over the past decade that we have not grown with it,” Marks said at Charles River’s Cell & Gene Summit Tour just outside of Boston.

article source